Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry

A.G. Dinmohamed; Y. van Norden; O. Visser; E.F.M. Posthuma; P.C. Huijgens; P. Sonneveld; A.A. van de Loosdrecht; M. Jongen-Lavrencic

doi:https://doi.org/10.1038/leu.2015.220

Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry

A.G. Dinmohamed, Y. van Norden, O. Visser, E.F.M. Posthuma, P.C. Huijgens, P. Sonneveld, A.A. van de Loosdrecht, M. Jongen-Lavrencic

Hematology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

33 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2449-2451
Journal	Leukemia
Volume	29
Issue number	12
DOIs	https://doi.org/10.1038/leu.2015.220
Publication status	Published - 2015

Access to Document

https://doi.org/10.1038/leu.2015.220

Cite this

Dinmohamed, A. G., van Norden, Y., Visser, O., Posthuma, E. F. M., Huijgens, P. C., Sonneveld, P., van de Loosdrecht, A. A., & Jongen-Lavrencic, M. (2015). Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry. Leukemia, 29(12), 2449-2451. https://doi.org/10.1038/leu.2015.220

@article{fa118619fae54a11829e595f5038eab8,

title = "Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry",

author = "A.G. Dinmohamed and {van Norden}, Y. and O. Visser and E.F.M. Posthuma and P.C. Huijgens and P. Sonneveld and {van de Loosdrecht}, A.A. and M. Jongen-Lavrencic",

year = "2015",

doi = "https://doi.org/10.1038/leu.2015.220",

language = "Undefined/Unknown",

volume = "29",

pages = "2449--2451",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "12",

}

Dinmohamed, AG, van Norden, Y, Visser, O, Posthuma, EFM, Huijgens, PC, Sonneveld, P, van de Loosdrecht, AA & Jongen-Lavrencic, M 2015, 'Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry', Leukemia, vol. 29, no. 12, pp. 2449-2451. https://doi.org/10.1038/leu.2015.220

TY - JOUR

T1 - Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry

AU - Dinmohamed, A.G.

AU - van Norden, Y.

AU - Visser, O.

AU - Posthuma, E.F.M.

AU - Huijgens, P.C.

AU - Sonneveld, P.

AU - van de Loosdrecht, A.A.

AU - Jongen-Lavrencic, M.

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1038/leu.2015.220

DO - https://doi.org/10.1038/leu.2015.220

M3 - Article

C2 - 26369829

SN - 0887-6924

VL - 29

SP - 2449

EP - 2451

JO - Leukemia

JF - Leukemia

IS - 12

ER -